Page 12 - "We note our non-risked valuation is $198.6m or $1.28/share (assuming 155.3m ordinary shares." Nice!!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025